Next week, we’re headed to Berlin, Germany to engage with leaders from around the world at #ESMOBreast24 . To learn more about our #BreastCancer clinical research to be presented at the congress, click here: rb.gy/0fcsba

Our Medical Affairs team has announced an Independent Medical Education Grant opportunity in collaboration with @Pfizer. The deadline is 6/27/24. Learn more: #mBC #MedicalEducation #CME Arvinas Oncology Medical

#NEWS : Today Arvinas ($ARVN) shared its Q1 2024 earnings and a business update.

Read the release here: rb.gy/r7p6n5

#BiotechNews #Investors

Check out the latest blog from our CEO, John Houston where he shares his vision, strategies, and the exciting journey ahead for Arvinas. Don't miss out on the opportunity to gain some valuable insights straight from the top! Read more here: rb.gy/mnz69f

#InTheNews : Arvinas ($ARVN) was featured in @PharmaShot following an interview w/ SVP of Neuroscience and Platform Biology, Angela Cacace, Ph.D. discussing the start of our Phase 1 trial for ARV-102, a potential treatment for #neurodegenerativediseases bit.ly/4dkdiRU

At Arvinas, we're inspired daily by the care, support, and compassion nurses have for patients. Join us in celebrating National Nurses Week 2024 and honoring nurses and the critical role they play in #healthcare . #NursesWeek #NursesLightUpTheSky

During #WomensHealthAwarenessMonth , we recognize the significant impact of breast cancer on women globally & remain committed to investigating innovative treatment options for those living with this disease.

Find more info & resources about breast cancer: bit.ly/3Q8flys

#TeamArvinas went green for #EarthMonth ! Our Sustainability Committee led events on sustainable commuting & climate change awareness w/ speakers from the #NHV Coalition of Active Transportation & Yale Program on Climate Change & ending w/ the #NHV Rock to Rock hiking/biking event

As #CancerControlMonth comes to an end, #TeamArvinas remains committed to our daily mission to improve the lives of patients by driving breakthroughs in #drugdiscovery and address unmet needs in #oncology .

Learn more about us here:  bit.ly/3TTT21E

From processing invoices to overseeing expense reports, Kayla Osbourne ensures smooth financial operations. Outside of work, she enjoys baking w/ her son & creative hobbies like painting & crafting.

Learn more about the members of #TeamArvinas here: rb.gy/lhp36x

#NEWS : Arvinas ($ARVN) enters into a transaction with Novartis, including a license agreement for Arvinas’ second generation PROTAC® androgen receptor (AR) degrader.

Read the full press release here: rb.gy/pvjft6

Big shoutout to all our amazing colleagues for representing #TPD so well at #AACR24 ! Let's keep pushing boundaries and making a difference together. #TeamArvinas

People are at the core of everything we do. #TeamArvinas is committed to pioneering science while listening to and learning from the communities we serve so that together, we can improve the lives of others.
Learn more about our commitment to patients: bit.ly/4anEOvy

Exciting news in the world of biotech! Our #PROTAC technology was featured in Forbes. Discover how this novel approach is for advancing both medicine and agriculture: rb.gy/y9vlrf

#BiotechInnovation #Arvinas

Arvinas ($ARVN) is traveling to #SanDiego to participate in the AACR Annual Meeting 2024 and present preclinical data for a #PROTAC BCL6 degrader. If you’re attending #AACR24 , we hope to see you there.

Happy #NationalDoctorsDay from #TeamArvinas !

Thank you to all the doctors, nurses, and other HCPs who make an impact on the lives of patients every day. #NationalPhysiciansWeek #DoctorsDay

This week Arvinas is presenting data at the #ASCPT2024 Annual Meeting (ASCPT Alexandria) in #ColoradoSprings . We look forward to connecting w/ other leaders in the industry and continuing our work to address unmet patient needs.

Learn more about $ARVN: bit.ly/4amcgSX

When he’s not looking for ways to develop an innovative patient support service platform, Sr. Dir, Patient Support Services Joe Sciacchitano likes to keep active & enjoys watching his kids play sports.

See what it’s like to be a part of #TeamArvinas : rb.gy/rm3e7q

#NEWS : Arvinas ($ARVN) appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer. Dr. Berkowitz will lead the ongoing clinical development of our PROTAC® protein degrader programs in #oncology and #neuroscience .

Read the full press release: bit.ly/3vrw9ZY

At #Arvinas , we are proud to have a team that drives growth scientifically and culturally. Our CEO John Houston believes building bonds of trust are essential to our goal of improving patient's lives.

Learn about #TeamArvinas : bit.ly/48ocXtx